Increasing Efficiency & Flexibility For The Clinical Supply Chain
Summary: Clinical trial supply is traditionally rigid and inflexible, with high material overages and lengthy production lead times. These factors combined can result in a lack of stockin the correct location, which can jeopardize the execution of trials, put patients at risk, increase pressure on clinical site workload, and increase costs of studies at a time when the industry is looking to improve efficiency, minimize risks, and shorten the trial duration. Drug Development & Delivery recently interviewed Wetteny Joseph, President of Clinical Supply Services at Catalent Pharma Solutions.
Read the article to learn about the changing nature of clinical trials and the supply of materials for studies, and how Catalent is investing in new solutions, systems, and facilities to assist the biopharmaceutical industry in bringing potentially life-changing therapies to patients, faster and more efficiently.